Meredith J. Pensak , MD,MPH

Bachelor of Arts: Wesleyan University Middletown, CT, 2004

Doctor of Medicine: University of Rochester School of Medicine and Dentistry Rochester, NY, 2012

MPH: Yale School of Public Health New Haven, CT, 2018

Residency: Pennsylvania Hospital Philadelphia, PA, 2016 (Obstetrics and Gynecology)

Fellowship: Yale School of Medicine New Haven, CT, 2018 (Complex Family Planning)

American Board of Obstetrics and Gynecology (Certification Date: 02-25-2019 ) - (Recertification Date: to 12-31-2023 )

Obstetrics and Gynecology

Abnormal Uterine Bleeding

Amenorrhea

Atrophic Vaginitis (Vaginal atrophy)

Bartholin's Cyst

Contraception

Ectopic Pregnancy

Heavy Menstrual periods (Menorrhagia)

Menopause

Menorrhagia (heavy menstrual bleeding)

Metrorrhagia

Miscarriage

Molar Pregnancy

Obstetric Labor

Pelvic Pain

Perimenopause

Pregnancy and Childbirth

Obstetrics and Gynecology

Grant: #75N94020D00011 Investigators:Pensak, Meredith; Thomas, Michael 08-01-2020 -07-31-2027 National Institute of Child Health and Human Development Contraceptive Development Program NICHD Contraceptive Clinical Trials Network Female Sites-Task 1 Role:Collaborator $12,938.00 Active Level:Federal

Grant: #21-001-P1-V01 06-01-2022 -05-31-2025 Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Syphilis Assay Intended Use Sample Collection Protocol Role:PI 107663.76 Hold Level:Industry

Grant: #21-001-P1-V01 06-01-2022 -05-31-2025 Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Syphilis Assay Intended Use Sample Collection Protocol Role:PI 107663.76 Hold Level:Industry

Grant: #21-001-P1-V01 06-01-2022 -05-31-2025 Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Syphilis Assay Intended Use Sample Collection Protocol Role:PI 107663.76 Hold Level:Industry

Grant: #21-001-P1-V01 06-01-2022 -05-31-2025 Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Syphilis Assay Intended Use Sample Collection Protocol Role:PI 107663.76 Hold Level:Industry

Grant: #OHSU (NICHD R01HD105866) Investigators:Pensak, Meredith; Thomas, Michael 09-20-2022 -06-30-2027 National Institute of Child Health and Human Development Disparities in emergency contraceptive metabolism dictate efficacy Role:Collaborator 331048.00 Hold Level:Federal

Grant: #OHSU 1020921 (R01HD105866) Investigators:Pensak, Meredith; Thomas, Michael 09-20-2022 -06-30-2027 National Institute of Child Health and Human Development Disparities in emergency contraceptive metabolism dictate efficacy Role:Collaborator 331048.00 Hold Level:Federal

Grant: #75N94020D00011 Investigators:Pensak, Meredith; Thomas, Michael 09-28-2023 -09-27-2024 National Institute of Child Health and Human Development Dr. Thomas's Ovaprene Task 2 proposal - Main Study Role:Collaborator 190857.00 Hold Level:Federal

Grant: #VITROS D59637 Investigators:Pensak, Meredith 02-15-2024 -02-15-2027 Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Progesterone 2 Assay Apparently Healthy Sample Collection Protocol Role:PI 618371.00 Hold Level:Industry